AMITRIPTYLINE HYDROCHLORIDE

AMITRIPTYLINE HYDROCHLORIDE was reported 18062 times

AMITRIPTYLINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CARDIOSPASM 383 0.6864
1 CFTR GENE MUTATION 15 0.6000
2 IMMUNISATION 258 0.5945
3 PALMOPLANTAR KERATODERMA 376 0.5186
4 SYNOVIAL FLUID ANALYSIS 42 0.4828
5 HEART SOUNDS 32 0.3333
6 DEVICE WIRELESS COMMUNICATION ISSUE 61 0.2355
7 ATRIAL TACHYCARDIA 391 0.1860
8 SEDATION COMPLICATION 430 0.1684
9 PRURITUS GENITAL 380 0.1612
10 DEVICE MAINTENANCE ISSUE 86 0.1463
11 PROLONGED EXPIRATION 32 0.1221
12 INFUSION SITE INJURY 21 0.1193
13 NEUTROPENIA NEONATAL 25 0.1116
14 CREATININE RENAL CLEARANCE DECREASED 436 0.1088
15 CAROTID ARTERY OCCLUSION 378 0.1035
16 TENOSYNOVITIS STENOSANS 50 0.0898
17 TENSION HEADACHE 384 0.0892
18 SLEEP TERROR 375 0.0890
19 MULTIPLE DRUG THERAPY 64 0.0849
20 INFUSION SITE DISCHARGE 142 0.0809
21 INFUSION SITE INDURATION 106 0.0715
22 INFUSION SITE IRRITATION 89 0.0693
23 INFUSION SITE WARMTH 83 0.0677
24 INFUSION SITE HAEMORRHAGE 212 0.0644
25 BODY TINEA 36 0.0643
26 INFUSION SITE DISCOLOURATION 55 0.0625
27 INFUSION SITE NODULE 59 0.0614
28 INFUSION SITE INFLAMMATION 43 0.0609
29 PATIENT DISSATISFACTION WITH DEVICE 15 0.0595
30 INFUSION SITE INFECTION 138 0.0593
31 INFUSION SITE PAIN 730 0.0566
32 ANTICHOLINERGIC SYNDROME 88 0.0552
33 CREATININE RENAL CLEARANCE INCREASED 41 0.0548
34 INFUSION SITE ERYTHEMA 455 0.0539
35 BRAIN MALFORMATION 19 0.0532
36 DEVICE INFUSION ISSUE 126 0.0508
37 INFUSION SITE SWELLING 315 0.0500
38 CARBON DIOXIDE ABNORMAL 14 0.0447
39 FACIAL PAIN 396 0.0443
40 CEREBELLAR STROKE 17 0.0435
41 FOETAL DISORDER 36 0.0431
42 INFUSION SITE DISCOMFORT 42 0.0405
43 BLOOD CALCIUM DECREASED 440 0.0391
44 INFUSION SITE CELLULITIS 20 0.0379
45 SUBARACHNOID HAEMORRHAGE 385 0.0378
46 CEREBRAL HYPOPERFUSION 17 0.0365
47 INFUSION SITE REACTION 109 0.0365
48 SYNOVIAL DISORDER 16 0.0352
49 SOMATIC SYMPTOM DISORDER 38 0.0352
50 INFUSION SITE VESICLES 18 0.0342
51 VASCULITIS 399 0.0342
52 INFUSION SITE PRURITUS 102 0.0323
53 INFUSION SITE MASS 34 0.0313
54 INFUSION SITE RASH 41 0.0299
55 ORTHOSTATIC HYPOTENSION 517 0.0297
56 SCLERITIS 45 0.0281
57 ANOSMIA 389 0.0268
58 INFUSION SITE BRUISING 58 0.0268
59 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 15 0.0267
60 INHIBITORY DRUG INTERACTION 41 0.0259
61 ALLERGY TO CHEMICALS 32 0.0257
62 WRIST DEFORMITY 15 0.0244
63 VENTRICULAR TACHYCARDIA 400 0.0242
64 PERICARDITIS 398 0.0237
65 GASTRIC PH DECREASED 24 0.0234
66 TENOSYNOVITIS 64 0.0232
67 DEVICE POWER SOURCE ISSUE 67 0.0229
68 COGWHEEL RIGIDITY 24 0.0229
69 DEVICE ALARM ISSUE 41 0.0226
70 COGNITIVE DISORDER 961 0.0206
71 SEDATION 538 0.0205
72 SACROILIITIS 38 0.0201
73 CEREBRAL VENTRICLE DILATATION 23 0.0199
74 ALLERGIC SINUSITIS 17 0.0198
75 PLEURITIC PAIN 52 0.0188
76 LIP PRURITUS 16 0.0187
77 MUSCLE TWITCHING 427 0.0185
78 PANCREATITIS RELAPSING 15 0.0183
79 CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY 19 0.0176
80 CREPITATIONS 51 0.0171
81 INFECTION SUSCEPTIBILITY INCREASED 37 0.0169
82 DIPLOPIA 435 0.0167
83 RHEUMATOID NODULE 46 0.0167
84 H1N1 INFLUENZA 23 0.0164
85 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 16 0.0159
86 LIP SWELLING 522 0.0157
87 ANTINUCLEAR ANTIBODY POSITIVE 50 0.0154
88 CUSHINGOID 48 0.0149
89 CARBON DIOXIDE DECREASED 17 0.0148
90 DEVICE CONNECTION ISSUE 31 0.0147
91 RENAL FUNCTION TEST ABNORMAL 67 0.0144
92 PAIN OF SKIN 386 0.0143
93 ENTHESOPATHY 22 0.0141
94 PURULENT DISCHARGE 58 0.0136
95 DEPRESSED LEVEL OF CONSCIOUSNESS 529 0.0134
96 HALLUCINATIONS, MIXED 56 0.0133
97 CLUSTER HEADACHE 18 0.0132
98 TRANSIENT ISCHAEMIC ATTACK 439 0.0130
99 RASH PAPULAR 291 0.0130
100 DEREALISATION 27 0.0125
101 DEPRESSIVE SYMPTOM 44 0.0125
102 EYE PRURITUS 398 0.0118
103 SUBSTANCE USE 18 0.0115
104 OESOPHAGEAL SPASM 21 0.0114
105 SYNOVIAL CYST 52 0.0113
106 TINNITUS 502 0.0109
107 ANGIOEDEMA 483 0.0109
108 ACUTE PSYCHOSIS 27 0.0109
109 EXOPHTHALMOS 23 0.0107
110 HEPATIC CYTOLYSIS 134 0.0105
111 BLINDNESS 425 0.0104
112 RENAL INFARCT 15 0.0104
113 FLANK PAIN 94 0.0100
114 SECONDARY ADRENOCORTICAL INSUFFICIENCY 15 0.0099
115 OLIGOHYDRAMNIOS 33 0.0099
116 DERMATITIS CONTACT 111 0.0097
117 PERIODONTITIS 21 0.0097
118 JOINT EFFUSION 66 0.0096
119 BURSITIS 116 0.0096
120 DISTURBANCE IN ATTENTION 515 0.0095
121 FOETAL GROWTH RESTRICTION 57 0.0094
122 DISORGANISED SPEECH 17 0.0092
123 SLOW SPEECH 22 0.0091
124 CATHETER SITE ERYTHEMA 19 0.0089
125 CATHETER SITE PAIN 23 0.0089
126 JAW FRACTURE 19 0.0088
127 SEROTONIN SYNDROME 167 0.0087
128 GLUCOSE TOLERANCE IMPAIRED 49 0.0083
129 HYPERLIPIDAEMIA 99 0.0083
130 OXYGEN CONSUMPTION INCREASED 19 0.0079
131 LIPIDS INCREASED 16 0.0079
132 PRODUCT ADMINISTRATION INTERRUPTED 62 0.0079
133 DERMATITIS PSORIASIFORM 16 0.0078
134 POISONING DELIBERATE 74 0.0078
135 MIGRAINE WITH AURA 21 0.0077
136 HALLUCINATION 574 0.0076
137 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 39 0.0076
138 SLEEP DEFICIT 16 0.0076
139 FIBROMYALGIA 183 0.0075
140 MUCOSAL DRYNESS 15 0.0074
141 AMNESIA 479 0.0074
142 MIGRAINE 701 0.0073
143 BALANCE DISORDER 633 0.0073
144 MIXED LIVER INJURY 22 0.0073
145 MOBILITY DECREASED 525 0.0073
146 DEVICE FAILURE 111 0.0073
147 HAEMOGLOBIN INCREASED 33 0.0072
148 DEVICE OCCLUSION 101 0.0072
149 RESPIRATION ABNORMAL 49 0.0071
150 FEELING OF DESPAIR 33 0.0071
151 ATELECTASIS 66 0.0068
152 RALES 39 0.0067
153 DEVICE PLACEMENT ISSUE 24 0.0067
154 HYPERVOLAEMIA 33 0.0067
155 CERVICAL VERTEBRAL FRACTURE 23 0.0067
156 TACHYCARDIA 592 0.0067
157 APPETITE DISORDER 44 0.0066
158 MYDRIASIS 85 0.0066
159 CLUMSINESS 18 0.0066
160 CATHETER SITE HAEMORRHAGE 16 0.0064
161 VENTRICULAR HYPERTROPHY 16 0.0064
162 TENDERNESS 66 0.0063
163 BREAST SWELLING 17 0.0063
164 HYPERREFLEXIA 22 0.0063
165 SEASONAL ALLERGY 86 0.0061
166 OESOPHAGEAL PAIN 24 0.0061
167 PURPURA 53 0.0060
168 FEELING OF BODY TEMPERATURE CHANGE 35 0.0060
169 MOUTH SWELLING 34 0.0059
170 HYPERTONIC BLADDER 17 0.0059
171 PRODUCT LEAKAGE 33 0.0059
172 VASCULAR DEVICE INFECTION 26 0.0057
173 ANXIETY DISORDER 19 0.0057
174 HYPERTONIA 32 0.0056
175 HYPERHIDROSIS 714 0.0055
176 IMPAIRED WORK ABILITY 118 0.0055
177 PALPITATIONS 642 0.0055
178 PHOTOPHOBIA 103 0.0055
179 HEART RATE INCREASED 542 0.0055
180 INTENTIONAL PRODUCT MISUSE 476 0.0054
181 DRUG TITRATION ERROR 14 0.0054
182 LOW BIRTH WEIGHT BABY 43 0.0054
183 SUBSTANCE USE DISORDER 17 0.0053
184 PAIN IN JAW 150 0.0053
185 EYE INJURY 16 0.0053
186 DEVICE KINK 19 0.0052
187 THERAPEUTIC PRODUCT INEFFECTIVE 20 0.0052
188 PULMONARY PAIN 15 0.0051
189 VISUAL IMPAIRMENT 622 0.0050
190 SWOLLEN TONGUE 153 0.0049
191 MUSCULAR WEAKNESS 555 0.0049
192 COMA 232 0.0049
193 HYPERTHERMIA 37 0.0048
194 SENSORY LOSS 39 0.0048
195 RESTLESS LEGS SYNDROME 88 0.0048
196 RESPIRATORY ACIDOSIS 19 0.0048
197 DEVICE PHYSICAL PROPERTY ISSUE 37 0.0048
198 POST-TRAUMATIC STRESS DISORDER 32 0.0048
199 NEURALGIA 116 0.0048
200 IMPAIRED QUALITY OF LIFE 68 0.0047
201 VENTRICULAR ARRHYTHMIA 17 0.0046
202 PANIC DISORDER 18 0.0046
203 HALLUCINATION, VISUAL 98 0.0046
204 INCONTINENCE 49 0.0046
205 PERIORBITAL OEDEMA 24 0.0046
206 FACET JOINT SYNDROME 15 0.0046
207 HYPOVENTILATION 15 0.0046
208 PREMATURE LABOUR 26 0.0046
209 DIABETIC FOOT 14 0.0046
210 DYSAESTHESIA 14 0.0046
211 CONJUNCTIVITIS 84 0.0045
212 MAJOR DEPRESSION 33 0.0045
213 THERAPY PARTIAL RESPONDER 70 0.0045
214 LYMPHOEDEMA 31 0.0045
215 PERIPHERAL SWELLING 688 0.0045
216 INCORRECT DRUG ADMINISTRATION RATE 19 0.0045
217 NIGHTMARE 154 0.0044
218 FEELING JITTERY 84 0.0044
219 TOXICITY TO VARIOUS AGENTS 739 0.0044
220 INTENTIONAL PRODUCT USE ISSUE 373 0.0043
221 MUSCLE DISORDER 34 0.0042
222 DROOLING 29 0.0042
223 SLEEP APNOEA SYNDROME 80 0.0042
224 MEMORY IMPAIRMENT 569 0.0041
225 PULMONARY TOXICITY 29 0.0041
226 HELICOBACTER INFECTION 42 0.0041
227 CHEST PAIN 751 0.0041
228 RESPIRATORY DEPRESSION 49 0.0040
229 INTERVERTEBRAL DISC DISORDER 17 0.0040
230 HYPOTENSION 795 0.0040
231 LOCALISED OEDEMA 18 0.0039
232 PAROSMIA 29 0.0038
233 DIABETIC NEUROPATHY 19 0.0038
234 NODULE 50 0.0038
235 DEHYDRATION 511 0.0038
236 DYSPNOEA EXERTIONAL 143 0.0038
237 IRON DEFICIENCY 17 0.0038
238 ULCER 60 0.0038
239 TRIGEMINAL NEURALGIA 15 0.0037
240 DEVICE INFORMATION OUTPUT ISSUE 29 0.0037
241 ANGINA PECTORIS 106 0.0037
242 ANGINA UNSTABLE 24 0.0037
243 MYOCLONUS 44 0.0037
244 BENIGN PROSTATIC HYPERPLASIA 19 0.0037
245 CONSTIPATION 800 0.0037
246 COMMUNICATION DISORDER 14 0.0037
247 DISSOCIATION 28 0.0036
248 EYE PAIN 205 0.0036
249 RASH MACULO-PAPULAR 80 0.0036
250 CHOLESTASIS 69 0.0036
251 DERMATITIS BULLOUS 26 0.0036
252 MULTIPLE ALLERGIES 28 0.0036
253 UNINTENTIONAL MEDICAL DEVICE REMOVAL 41 0.0035
254 INSURANCE ISSUE 54 0.0035
255 THERAPY NON-RESPONDER 158 0.0035
256 CEREBRAL ATROPHY 14 0.0035
257 DIZZINESS POSTURAL 34 0.0035
258 POOR QUALITY SLEEP 75 0.0035
259 ABDOMINAL DISCOMFORT 584 0.0035
260 BREAST PAIN 37 0.0035
261 CORONARY ARTERY DISEASE 105 0.0035
262 COMPLETED SUICIDE 287 0.0034
263 COVID-19 604 0.0034
264 MUSCLE RIGIDITY 41 0.0034
265 MULTIPLE DRUG OVERDOSE 17 0.0034
266 DRY SKIN 452 0.0034
267 SKIN ABRASION 16 0.0034
268 DRUG INTERACTION 536 0.0034
269 PHARYNGEAL SWELLING 33 0.0034
270 GINGIVITIS 18 0.0033
271 MYOCARDIAL INFARCTION 582 0.0033
272 UPPER RESPIRATORY TRACT INFECTION 154 0.0033
273 BEHAVIOUR DISORDER 18 0.0033
274 BLADDER DISORDER 33 0.0033
275 SOPOR 44 0.0033
276 BACK PAIN 771 0.0033
277 PULMONARY ARTERIAL HYPERTENSION 48 0.0033
278 PERIPHERAL VASCULAR DISORDER 17 0.0033
279 HYPERAESTHESIA 27 0.0033
280 NECK PAIN 183 0.0033
281 BUNDLE BRANCH BLOCK RIGHT 15 0.0033
282 FALL 1078 0.0032
283 LIGAMENT SPRAIN 32 0.0032
284 ABNORMAL LOSS OF WEIGHT 22 0.0032
285 GASTRITIS EROSIVE 15 0.0032
286 SPINAL OSTEOARTHRITIS 28 0.0032
287 BRUXISM 17 0.0031
288 DRUG ABUSE 262 0.0031
289 INSOMNIA 834 0.0031
290 CYANOSIS 49 0.0031
291 HEAD DISCOMFORT 55 0.0031
292 DEFORMITY 29 0.0031
293 ABDOMINAL PAIN UPPER 637 0.0031
294 WHEEZING 183 0.0031
295 CHOKING SENSATION 17 0.0031
296 PULMONARY HYPERTENSION 64 0.0031
297 SWELLING FACE 200 0.0031
298 TORSADE DE POINTES 24 0.0031
299 URINARY RETENTION 102 0.0031
300 ANXIETY 869 0.0031
301 FEELING ABNORMAL 731 0.0030
302 SYNOVITIS 55 0.0030
303 STAPHYLOCOCCAL SEPSIS 15 0.0030
304 INTERVERTEBRAL DISC DEGENERATION 28 0.0030
305 AGITATION 222 0.0030
306 ABDOMINAL TENDERNESS 15 0.0030
307 MENSTRUAL DISORDER 25 0.0030
308 DEVICE DISLOCATION 131 0.0030
309 PARALYSIS 43 0.0030
310 MITRAL VALVE INCOMPETENCE 34 0.0030
311 CORONARY ARTERY STENOSIS 15 0.0030
312 RHINITIS 24 0.0030
313 C-REACTIVE PROTEIN ABNORMAL 19 0.0030
314 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 50 0.0029
315 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 30 0.0029
316 ASTHENOPIA 16 0.0029
317 BRADYPHRENIA 19 0.0029
318 JOINT RANGE OF MOTION DECREASED 39 0.0029
319 PERSONALITY CHANGE 27 0.0029
320 CARDIO-RESPIRATORY ARREST 121 0.0029
321 ENERGY INCREASED 17 0.0029
322 EMPHYSEMA 29 0.0029
323 BODY TEMPERATURE DECREASED 28 0.0028
324 PNEUMONIA ASPIRATION 71 0.0028
325 ELECTROCARDIOGRAM QT PROLONGED 101 0.0028
326 CYSTITIS 89 0.0028
327 TENSION 17 0.0028
328 C-REACTIVE PROTEIN INCREASED 101 0.0028
329 ARTERIOSCLEROSIS 26 0.0028
330 SCIATICA 44 0.0028
331 SKIN LACERATION 30 0.0028
332 SKIN ULCER 71 0.0027
333 PAIN 1684 0.0027
334 DRUG USE DISORDER 23 0.0027
335 GROIN PAIN 24 0.0027
336 PHARYNGEAL OEDEMA 42 0.0027
337 CEREBRAL ISCHAEMIA 14 0.0027
338 CONFUSIONAL STATE 437 0.0027
339 DERMATITIS ALLERGIC 34 0.0027
340 HYPOKINESIA 39 0.0027
341 INTERMENSTRUAL BLEEDING 15 0.0027
342 QUALITY OF LIFE DECREASED 36 0.0027
343 BRAIN FOG 42 0.0027
344 DEVICE USE ERROR 93 0.0027
345 SINUS TACHYCARDIA 38 0.0027
346 PSYCHOTIC DISORDER 79 0.0027
347 DELIRIUM 92 0.0026
348 DISORIENTATION 105 0.0026
349 BONE DENSITY DECREASED 83 0.0026
350 PANIC REACTION 19 0.0026
351 DYSTONIA 51 0.0026
352 MIOSIS 21 0.0026
353 ORAL HERPES 51 0.0026
354 HEREDITARY ANGIOEDEMA 28 0.0026
355 DYSPNOEA 1468 0.0026
356 SOMNAMBULISM 17 0.0026
357 SKIN WARM 15 0.0026
358 MUSCULOSKELETAL PAIN 135 0.0026
359 JOINT INJURY 55 0.0026
360 HYPONATRAEMIA 145 0.0026
361 APPENDICITIS 24 0.0026
362 MOOD ALTERED 70 0.0026
363 ILLNESS 264 0.0026
364 SWELLING OF EYELID 16 0.0025
365 BRADYKINESIA 15 0.0025
366 ATRIOVENTRICULAR BLOCK COMPLETE 17 0.0025
367 MICTURITION URGENCY 29 0.0025
368 ACUTE CORONARY SYNDROME 21 0.0025
369 MUSCULOSKELETAL STIFFNESS 222 0.0025
370 NEUROLEPTIC MALIGNANT SYNDROME 30 0.0025
371 MALAISE 1108 0.0025
372 DIZZINESS 1260 0.0025
373 IRRITABLE BOWEL SYNDROME 54 0.0025
374 COORDINATION ABNORMAL 35 0.0025
375 CARPAL TUNNEL SYNDROME 35 0.0025
376 DRUG TOXICITY 34 0.0025
377 DRY MOUTH 202 0.0025
378 BLOOD GLUCOSE INCREASED 469 0.0025
379 HYPERCHOLESTEROLAEMIA 24 0.0025
380 EYE MOVEMENT DISORDER 17 0.0025
381 ALOPECIA 487 0.0025
382 SLEEP DISORDER 175 0.0025
383 OESOPHAGITIS 27 0.0025
384 SUICIDAL IDEATION 226 0.0025
385 CIRCULATORY COLLAPSE 42 0.0025
386 PNEUMOTHORAX 39 0.0025
387 DEPRESSED MOOD 130 0.0025
388 HYPOAESTHESIA ORAL 37 0.0025
389 SCAR 42 0.0025
390 ALTERED STATE OF CONSCIOUSNESS 53 0.0024
391 DELUSION 38 0.0024
392 GASTRITIS 64 0.0024
393 ARTHRALGIA 1009 0.0024
394 AFFECTIVE DISORDER 19 0.0024
395 HEADACHE 1509 0.0024
396 HYPOTONIA 24 0.0024
397 PRE-EXISTING CONDITION IMPROVED 15 0.0024
398 NEPHROLITHIASIS 110 0.0024
399 PYREXIA 829 0.0024
400 CELLULITIS 120 0.0024
401 CONTRAINDICATED PRODUCT ADMINISTERED 72 0.0024
402 DECREASED INTEREST 14 0.0024
403 MANIA 39 0.0024
404 CARDIOGENIC SHOCK 34 0.0024
405 JOINT SWELLING 286 0.0024
406 DYSARTHRIA 89 0.0024
407 GLOMERULAR FILTRATION RATE DECREASED 29 0.0024
408 VITAMIN D DEFICIENCY 23 0.0024
409 TOOTH ABSCESS 24 0.0024
410 TOOTH INFECTION 31 0.0023
411 OSTEOARTHRITIS 99 0.0023
412 INTERVERTEBRAL DISC PROTRUSION 51 0.0023
413 FOOD ALLERGY 18 0.0023
414 GASTROENTERITIS 34 0.0023
415 URINARY INCONTINENCE 69 0.0023
416 SPINAL DISORDER 22 0.0023
417 LIMB INJURY 63 0.0023
418 HIATUS HERNIA 30 0.0023
419 OXYGEN SATURATION DECREASED 130 0.0023
420 NOCTURIA 28 0.0023
421 PRODUCTIVE COUGH 110 0.0023
422 AUTOIMMUNE HEPATITIS 16 0.0023
423 TENDON DISORDER 15 0.0023
424 VOMITING 1081 0.0023
425 ADVERSE DRUG REACTION 206 0.0023
426 SOMNOLENCE 461 0.0023
427 HAND DEFORMITY 30 0.0023
428 PRURITUS 876 0.0023
429 MUSCLE SPASTICITY 28 0.0023
430 CHEST DISCOMFORT 233 0.0023
431 DEVICE RELATED INFECTION 35 0.0023
432 BRONCHITIS 168 0.0023
433 SUDDEN DEATH 24 0.0023
434 MUSCULOSKELETAL CHEST PAIN 35 0.0023
435 DIVERTICULUM 16 0.0022
436 ELECTROLYTE IMBALANCE 26 0.0022
437 ORAL PAIN 50 0.0022
438 BLEPHAROSPASM 14 0.0022
439 SPINAL PAIN 26 0.0022
440 SPUTUM DISCOLOURED 21 0.0022
441 GENERAL PHYSICAL CONDITION ABNORMAL 15 0.0022
442 BIPOLAR DISORDER 24 0.0022
443 AGRANULOCYTOSIS 41 0.0022
444 HYPERSOMNIA 63 0.0022
445 BLOOD CHOLESTEROL INCREASED 102 0.0022
446 APHASIA 66 0.0022
447 MOUTH ULCERATION 46 0.0022
448 ROTATOR CUFF SYNDROME 28 0.0022
449 WRIST FRACTURE 26 0.0022
450 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 154 0.0022
451 FLUID RETENTION 110 0.0022
452 PRODUCT DISTRIBUTION ISSUE 20 0.0022
453 LUNG DISORDER 105 0.0021
454 RIGHT VENTRICULAR FAILURE 15 0.0021
455 CONTUSION 206 0.0021
456 OCULAR DISCOMFORT 24 0.0021
457 POOR VENOUS ACCESS 22 0.0021
458 BLOOD DISORDER 17 0.0021
459 THERAPEUTIC PRODUCT EFFECT DECREASED 95 0.0021
460 HEPATOCELLULAR INJURY 30 0.0021
461 BACK INJURY 23 0.0021
462 MENINGIOMA 33 0.0021
463 HEAVY MENSTRUAL BLEEDING 19 0.0021
464 ASPIRATION 23 0.0021
465 SPEECH DISORDER 110 0.0021
466 SUICIDE ATTEMPT 127 0.0021
467 BACK DISORDER 34 0.0021
468 SUPRAVENTRICULAR TACHYCARDIA 20 0.0021
469 SUBSTANCE ABUSE 17 0.0021
470 GASTROOESOPHAGEAL REFLUX DISEASE 168 0.0021
471 PANIC ATTACK 76 0.0021
472 HYPOKALAEMIA 96 0.0021
473 ACCIDENTAL OVERDOSE 76 0.0021
474 INTENTIONAL OVERDOSE 133 0.0021
475 HYPOXIA 73 0.0021
476 BLOOD SODIUM DECREASED 39 0.0021
477 VERTIGO 126 0.0021
478 DRY EYE 103 0.0021
479 IRON DEFICIENCY ANAEMIA 19 0.0021
480 DEPRESSION 468 0.0021
481 IMPAIRED GASTRIC EMPTYING 28 0.0021
482 LIVER DISORDER 91 0.0020
483 RESTLESSNESS 75 0.0020
484 PANCREATITIS ACUTE 46 0.0020
485 MOOD SWINGS 65 0.0020
486 LIMB DISCOMFORT 63 0.0020
487 DIARRHOEA HAEMORRHAGIC 19 0.0020
488 OEDEMA 110 0.0020
489 PREMATURE BABY 61 0.0020
490 ASTHMA 228 0.0020
491 BLOOD CREATINE PHOSPHOKINASE INCREASED 58 0.0020
492 TRICUSPID VALVE INCOMPETENCE 16 0.0020
493 PARAESTHESIA 316 0.0020
494 GASTROINTESTINAL INFECTION 18 0.0020
495 HYPOCALCAEMIA 38 0.0020
496 ACUTE KIDNEY INJURY 306 0.0020
497 NAUSEA 1576 0.0020
498 PAIN IN EXTREMITY 580 0.0020
499 DRUG INTOLERANCE 190 0.0020
500 BLOOD PRESSURE SYSTOLIC INCREASED 38 0.0019
501 INFLAMMATORY BOWEL DISEASE 19 0.0019
502 ATAXIA 23 0.0019
503 HYPERTENSION 410 0.0019
504 APHTHOUS ULCER 15 0.0019
505 HEPATIC STEATOSIS 36 0.0019
506 PULMONARY THROMBOSIS 21 0.0019
507 POLYNEUROPATHY 23 0.0019
508 APATHY 28 0.0019
509 RASH PRURITIC 104 0.0019
510 DEVICE LEAKAGE 83 0.0019
511 EYE IRRITATION 110 0.0019
512 OSTEOPENIA 29 0.0019
513 GASTROINTESTINAL PAIN 21 0.0019
514 FATIGUE 1480 0.0019
515 LETHARGY 109 0.0019
516 PERIPHERAL COLDNESS 26 0.0019
517 SCHIZOPHRENIA 23 0.0019
518 DIARRHOEA 1220 0.0019
519 SKIN DISORDER 63 0.0019
520 BLISTER 106 0.0019
521 OEDEMA PERIPHERAL 230 0.0019
522 THROAT TIGHTNESS 51 0.0019
523 PULMONARY MASS 28 0.0019
524 HYPOTHYROIDISM 60 0.0019
525 FEMUR FRACTURE 58 0.0019
526 ECZEMA 98 0.0019
527 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 48 0.0019
528 NEUTROPHIL COUNT INCREASED 19 0.0019
529 BLOOD IRON DECREASED 22 0.0019
530 DECREASED ACTIVITY 20 0.0019
531 SINUS CONGESTION 25 0.0018
532 PYELONEPHRITIS 16 0.0018
533 EPILEPSY 56 0.0018
534 ACIDOSIS 14 0.0018
535 STOMATITIS 111 0.0018
536 HALLUCINATION, AUDITORY 29 0.0018
537 LOWER RESPIRATORY TRACT INFECTION 83 0.0018
538 BRONCHOSPASM 26 0.0018
539 RED BLOOD CELL COUNT DECREASED 52 0.0018
540 PHOTOSENSITIVITY REACTION 30 0.0018
541 WEIGHT FLUCTUATION 19 0.0018
542 MUSCLE ATROPHY 23 0.0018
543 ATRIOVENTRICULAR BLOCK 14 0.0018
544 ANAPHYLACTIC REACTION 100 0.0018
545 ACUTE RESPIRATORY DISTRESS SYNDROME 32 0.0018
546 MOVEMENT DISORDER 58 0.0018
547 EAR INFECTION 48 0.0018
548 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 14 0.0018
549 APNOEA 14 0.0018
550 OBSTRUCTIVE AIRWAYS DISORDER 20 0.0018
551 RHEUMATOID ARTHRITIS 204 0.0018
552 HYPOMAGNESAEMIA 25 0.0018
553 DEMENTIA 50 0.0018
554 SKIN INFECTION 20 0.0018
555 MYALGIA 303 0.0018
556 PHARYNGITIS 22 0.0018
557 EYELID PTOSIS 18 0.0018
558 PRESYNCOPE 43 0.0018
559 ABDOMINAL PAIN 411 0.0018
560 BLOOD ALBUMIN DECREASED 14 0.0018
561 BLOOD POTASSIUM DECREASED 53 0.0018
562 FEELING COLD 49 0.0018
563 DEVICE ADHESION ISSUE 27 0.0018
564 FACIAL PARALYSIS 15 0.0018
565 AGGRESSION 88 0.0018
566 MYOCARDIAL ISCHAEMIA 20 0.0018
567 DYSPEPSIA 172 0.0017
568 MUSCULOSKELETAL DISCOMFORT 30 0.0017
569 PARANOIA 30 0.0017
570 IMPAIRED HEALING 57 0.0017
571 NASAL CONGESTION 102 0.0017
572 INTENTIONAL SELF-INJURY 35 0.0017
573 PALLOR 47 0.0017
574 SINUSITIS 177 0.0017
575 SWELLING 161 0.0017
576 FACE OEDEMA 29 0.0017
577 GASTROENTERITIS VIRAL 31 0.0017
578 SINUS DISORDER 34 0.0017
579 RASH MACULAR 60 0.0017
580 ACUTE RESPIRATORY FAILURE 33 0.0017
581 HEPATIC ENCEPHALOPATHY 16 0.0017
582 TOOTH DISORDER 38 0.0017
583 GASTROINTESTINAL DISORDER 153 0.0017
584 TREMOR 282 0.0017
585 PSYCHOMOTOR HYPERACTIVITY 28 0.0017
586 GASTRIC ULCER 32 0.0017
587 TENDONITIS 26 0.0017
588 ARTHRITIS 132 0.0017
589 DYSKINESIA 68 0.0017
590 SYNCOPE 167 0.0017
591 OCULAR HYPERAEMIA 79 0.0017
592 AFFECT LABILITY 16 0.0017
593 INCORRECT PRODUCT ADMINISTRATION DURATION 36 0.0017
594 CRYING 60 0.0016
595 LIVER FUNCTION TEST ABNORMAL 48 0.0016
596 MENTAL IMPAIRMENT 40 0.0016
597 AUTOIMMUNE DISORDER 16 0.0016
598 INFLUENZA 182 0.0016
599 OBESITY 26 0.0016
600 RHABDOMYOLYSIS 68 0.0016
601 VITREOUS FLOATERS 16 0.0016
602 DENTAL CARIES 18 0.0016
603 CARDIOMEGALY 20 0.0016
604 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 78 0.0016
605 HYPOAESTHESIA 243 0.0016
606 BRADYCARDIA 86 0.0016
607 CATARACT 96 0.0016
608 OVARIAN CYST 16 0.0016
609 PERICARDIAL EFFUSION 37 0.0016
610 RHINORRHOEA 103 0.0016
611 ANKYLOSING SPONDYLITIS 21 0.0016
612 MENTAL STATUS CHANGES 44 0.0016
613 RASH 690 0.0016
614 HOT FLUSH 119 0.0016
615 RESPIRATORY TRACT CONGESTION 25 0.0016
616 ABDOMINAL DISTENSION 164 0.0016
617 INFLAMMATION 81 0.0016
618 BURNING SENSATION 110 0.0016
619 WEIGHT INCREASED 351 0.0016
620 DEVICE ISSUE 140 0.0016
621 INITIAL INSOMNIA 16 0.0016
622 ANAL INCONTINENCE 14 0.0016
623 RIB FRACTURE 32 0.0016
624 BACTERIAL INFECTION 29 0.0016
625 WOUND INFECTION 17 0.0016
626 NIGHT SWEATS 50 0.0016
627 ANKLE FRACTURE 24 0.0015
628 UVEITIS 21 0.0015
629 TOOTHACHE 28 0.0015
630 LOSS OF CONSCIOUSNESS 198 0.0015
631 HYPERCALCAEMIA 19 0.0015
632 CORONARY ARTERY OCCLUSION 21 0.0015
633 COUGH 428 0.0015
634 HYPOGLYCAEMIA 74 0.0015
635 PARAESTHESIA ORAL 22 0.0015
636 MALNUTRITION 17 0.0015
637 ORAL DISCOMFORT 21 0.0015
638 UNRESPONSIVE TO STIMULI 39 0.0015
639 PRODUCT USE IN UNAPPROVED INDICATION 374 0.0015
640 GLAUCOMA 29 0.0015
641 UPPER LIMB FRACTURE 30 0.0015
642 MASS 21 0.0015
643 BLOOD PRESSURE FLUCTUATION 36 0.0015
644 RESPIRATORY TRACT INFECTION 39 0.0015
645 HERPES ZOSTER 86 0.0015
646 SKIN LESION 41 0.0015
647 DYSURIA 55 0.0015
648 MENTAL DISORDER 65 0.0015
649 PRODUCT AVAILABILITY ISSUE 34 0.0015
650 ACUTE MYOCARDIAL INFARCTION 44 0.0015
651 INTESTINAL OBSTRUCTION 56 0.0015
652 HEAD INJURY 47 0.0015
653 HEPATITIS 38 0.0015
654 MUSCLE TIGHTNESS 24 0.0015
655 CANDIDA INFECTION 25 0.0015
656 VISION BLURRED 203 0.0015
657 GASTRIC HAEMORRHAGE 17 0.0015
658 WEIGHT DECREASED 412 0.0015
659 MATERNAL EXPOSURE DURING PREGNANCY 131 0.0015
660 SMALL INTESTINAL OBSTRUCTION 18 0.0015
661 INTERSTITIAL LUNG DISEASE 70 0.0014
662 MUSCLE SPASMS 265 0.0014
663 PNEUMONIA 467 0.0014
664 EAR PAIN 28 0.0014
665 LEUKOCYTOSIS 26 0.0014
666 PRURITUS GENERALISED 31 0.0014
667 PULMONARY OEDEMA 64 0.0014
668 CHOLECYSTITIS 17 0.0014
669 FOOT FRACTURE 27 0.0014
670 BLOOD TEST ABNORMAL 20 0.0014
671 FLUSHING 144 0.0014
672 SKIN DISCOLOURATION 65 0.0014
673 PRODUCT DOSE OMISSION IN ERROR 40 0.0014
674 DRUG ERUPTION 25 0.0014
675 WITHDRAWAL SYNDROME 59 0.0014
676 THROMBOSIS 113 0.0014
677 EPISTAXIS 105 0.0014
678 CHOLECYSTECTOMY 16 0.0014
679 NEUROPATHY PERIPHERAL 133 0.0014
680 BRAIN INJURY 14 0.0014
681 TYPE 2 DIABETES MELLITUS 47 0.0014
682 TRANSAMINASES INCREASED 31 0.0014
683 PHARYNGITIS STREPTOCOCCAL 15 0.0014
684 ECONOMIC PROBLEM 21 0.0014
685 OSTEOMYELITIS 25 0.0014
686 FEEDING DISORDER 28 0.0014
687 RASH ERYTHEMATOUS 66 0.0014
688 DEAFNESS 36 0.0014
689 SEIZURE 159 0.0014
690 BODY TEMPERATURE INCREASED 28 0.0014
691 COLITIS 52 0.0014
692 LOCALISED INFECTION 33 0.0014
693 MELAENA 30 0.0014
694 INCREASED APPETITE 26 0.0014
695 TOOTH FRACTURE 15 0.0014
696 THROAT IRRITATION 61 0.0014
697 SECRETION DISCHARGE 17 0.0014
698 GAIT DISTURBANCE 258 0.0013
699 NERVOUS SYSTEM DISORDER 42 0.0013
700 GALLBLADDER DISORDER 24 0.0013
701 RENAL FAILURE ACUTE 57 0.0013
702 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 70 0.0013
703 HAEMATEMESIS 34 0.0013
704 MULTIPLE SCLEROSIS 64 0.0013
705 EMOTIONAL DISORDER 41 0.0013
706 COAGULOPATHY 22 0.0013
707 PREMATURE DELIVERY 21 0.0013
708 BONE DISORDER 24 0.0013
709 BLOOD UREA INCREASED 22 0.0013
710 CHOLELITHIASIS 43 0.0013
711 DECREASED APPETITE 304 0.0013
712 PRODUCT DOSE OMISSION ISSUE 384 0.0013
713 ERYTHEMA 268 0.0013
714 LIVER INJURY 32 0.0013
715 JOINT STIFFNESS 34 0.0013
716 URINARY TRACT INFECTION 221 0.0013
717 ARTHROPATHY 72 0.0013
718 ORAL CANDIDIASIS 17 0.0013
719 ROAD TRAFFIC ACCIDENT 54 0.0013
720 PRODUCT ADMINISTRATION ERROR 26 0.0013
721 TUBULOINTERSTITIAL NEPHRITIS 24 0.0013
722 FOETAL EXPOSURE DURING PREGNANCY 104 0.0013
723 HAEMATOMA 33 0.0013
724 DIABETES MELLITUS 97 0.0013
725 COVID-19 PNEUMONIA 15 0.0013
726 GENERALISED TONIC-CLONIC SEIZURE 21 0.0013
727 ASTHENIA 477 0.0013
728 TREATMENT FAILURE 105 0.0013
729 RETCHING 27 0.0013
730 RENAL DISORDER 59 0.0013
731 ABDOMINAL PAIN LOWER 32 0.0013
732 OVERDOSE 273 0.0013
733 DYSPHAGIA 120 0.0013
734 GAMMA-GLUTAMYLTRANSFERASE INCREASED 28 0.0013
735 INTERNATIONAL NORMALISED RATIO INCREASED 36 0.0013
736 VIRAL INFECTION 42 0.0013
737 INFECTION 182 0.0013
738 GAIT INABILITY 42 0.0013
739 FEELING HOT 77 0.0013
740 OROPHARYNGEAL PAIN 116 0.0013
741 GLOSSODYNIA 28 0.0012
742 LYMPHOCYTE COUNT DECREASED 22 0.0012
743 INJURY 87 0.0012
744 CHRONIC KIDNEY DISEASE 94 0.0012
745 THIRST 22 0.0012
746 DIVERTICULITIS 34 0.0012
747 OFF LABEL USE 1070 0.0012
748 THERAPEUTIC RESPONSE DECREASED 74 0.0012
749 HAEMOPTYSIS 34 0.0012
750 PRODUCT PRESCRIBING ERROR 29 0.0012
751 GENERALISED OEDEMA 15 0.0012
752 SYSTEMIC LUPUS ERYTHEMATOSUS 43 0.0012
753 PROTEINURIA 23 0.0012
754 DEVICE MALFUNCTION 85 0.0012
755 CYST 15 0.0012
756 GASTROINTESTINAL HAEMORRHAGE 101 0.0012
757 BLOOD PRESSURE ABNORMAL 24 0.0012
758 HYPERSENSITIVITY 224 0.0012
759 NEEDLE ISSUE 35 0.0012
760 DEVICE USE ISSUE 21 0.0012
761 NASOPHARYNGITIS 221 0.0012
762 SPINAL FRACTURE 24 0.0012
763 POST PROCEDURAL COMPLICATION 23 0.0012
764 IRRITABILITY 72 0.0012
765 ABSCESS 19 0.0012
766 FEAR 32 0.0012
767 METABOLIC ACIDOSIS 38 0.0012
768 OSTEONECROSIS 39 0.0012
769 STAPHYLOCOCCAL INFECTION 39 0.0012
770 HEMIPARESIS 20 0.0012
771 BACTERAEMIA 14 0.0012
772 KIDNEY INFECTION 23 0.0012
773 COMPLICATION ASSOCIATED WITH DEVICE 17 0.0012
774 HYPERKALAEMIA 41 0.0012
775 OSTEOPOROSIS 48 0.0012
776 URTICARIA 195 0.0012
777 FLATULENCE 66 0.0012
778 CARDIAC ARREST 96 0.0012
779 ABNORMAL BEHAVIOUR 46 0.0012
780 HAEMATOCRIT DECREASED 23 0.0012
781 ABNORMAL DREAMS 32 0.0012
782 ANGER 39 0.0012
783 TREATMENT NONCOMPLIANCE 63 0.0012
784 END STAGE RENAL DISEASE 21 0.0012
785 CARDIOMYOPATHY 17 0.0011
786 HUNGER 16 0.0011
787 CONDITION AGGRAVATED 349 0.0011
788 AMENORRHOEA 20 0.0011
789 IMMUNODEFICIENCY 17 0.0011
790 RESPIRATORY FAILURE 83 0.0011
791 ABNORMAL WEIGHT GAIN 14 0.0011
792 EYE SWELLING 42 0.0011
793 EATING DISORDER 24 0.0011
794 ASCITES 33 0.0011
795 TOXIC EPIDERMAL NECROLYSIS 17 0.0011
796 ARRHYTHMIA 53 0.0011
797 LIVER FUNCTION TEST INCREASED 24 0.0011
798 WOUND 31 0.0011
799 NEOPLASM MALIGNANT 74 0.0011
800 CEREBROVASCULAR ACCIDENT 187 0.0011
801 THYROID DISORDER 17 0.0011
802 ANAEMIA 210 0.0011
803 BLOOD PRESSURE DECREASED 73 0.0011
804 PULMONARY FIBROSIS 21 0.0011
805 BONE PAIN 64 0.0011
806 HAEMOGLOBIN DECREASED 112 0.0011
807 INTENTIONAL DOSE OMISSION 31 0.0011
808 HAEMATOCHEZIA 60 0.0011
809 SHOCK 25 0.0011
810 DISCOMFORT 66 0.0011
811 DRUG EFFECT LESS THAN EXPECTED 16 0.0011
812 LEUKOPENIA 54 0.0011
813 HAEMORRHOIDS 21 0.0011
814 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 194 0.0011
815 CHOKING 21 0.0011
816 APHONIA 15 0.0011
817 CARDIAC FAILURE CONGESTIVE 86 0.0011
818 HYPOACUSIS 46 0.0011
819 EYE DISORDER 35 0.0011
820 HEART RATE IRREGULAR 24 0.0011
821 DISABILITY 21 0.0011
822 DYSSTASIA 31 0.0011
823 LYMPHOPENIA 15 0.0011
824 ALANINE AMINOTRANSFERASE INCREASED 65 0.0011
825 INFLUENZA LIKE ILLNESS 87 0.0011
826 MUSCULOSKELETAL DISORDER 20 0.0010
827 OSTEONECROSIS OF JAW 26 0.0010
828 FUNGAL INFECTION 35 0.0010
829 CARDIAC DISORDER 98 0.0010
830 RASH GENERALISED 27 0.0010
831 ATRIAL FIBRILLATION 101 0.0010
832 NERVOUSNESS 54 0.0010
833 HEPATOTOXICITY 23 0.0010
834 POLLAKIURIA 43 0.0010
835 DRUG LEVEL INCREASED 17 0.0010
836 RENAL FAILURE 136 0.0010
837 CARDIOVASCULAR DISORDER 26 0.0010
838 SKIN FISSURES 20 0.0010
839 CARDIAC FAILURE 82 0.0010
840 ENCEPHALOPATHY 25 0.0010
841 WHITE BLOOD CELL COUNT INCREASED 39 0.0010
842 DEVICE DIFFICULT TO USE 67 0.0010
843 PSORIATIC ARTHROPATHY 41 0.0010
844 INTENTIONAL DRUG MISUSE 21 0.0010
845 GOUT 18 0.0010
846 DEEP VEIN THROMBOSIS 65 0.0010
847 RENAL IMPAIRMENT 84 0.0010
848 KNEE ARTHROPLASTY 21 0.0010
849 HEART RATE DECREASED 35 0.0010
850 MULTIPLE SCLEROSIS RELAPSE 68 0.0010
851 PNEUMONITIS 27 0.0010
852 MEDICATION ERROR 55 0.0010
853 LOWER LIMB FRACTURE 19 0.0010
854 LYMPHADENOPATHY 35 0.0010
855 HYPERGLYCAEMIA 36 0.0010
856 HERNIA 19 0.0010
857 CONVULSION 56 0.0010
858 THROMBOCYTOPENIA 109 0.0010
859 RESPIRATORY DISORDER 29 0.0010
860 GENERAL PHYSICAL HEALTH DETERIORATION 112 0.0010
861 COLD SWEAT 17 0.0010
862 CLOSTRIDIUM DIFFICILE INFECTION 21 0.0010
863 DIABETES MELLITUS INADEQUATE CONTROL 17 0.0010
864 MUCOSAL INFLAMMATION 25 0.0010
865 PRODUCT USE COMPLAINT 15 0.0010
866 RESPIRATORY ARREST 26 0.0009
867 FULL BLOOD COUNT DECREASED 19 0.0009
868 PLEURAL EFFUSION 57 0.0009
869 TASTE DISORDER 19 0.0009
870 PRODUCT USE ISSUE 176 0.0009
871 ERUCTATION 18 0.0009
872 CHILLS 109 0.0009
873 EXPOSURE VIA SKIN CONTACT 24 0.0009
874 PULMONARY EMBOLISM 88 0.0009
875 BLOOD POTASSIUM INCREASED 15 0.0009
876 DIABETIC KETOACIDOSIS 22 0.0009
877 SEPSIS 102 0.0009
878 PANCREATITIS 48 0.0009
879 APPLICATION SITE PAIN 20 0.0009
880 RECTAL HAEMORRHAGE 39 0.0009
881 DYSPHONIA 53 0.0009
882 INFUSION RELATED REACTION 60 0.0009
883 HYPOPHAGIA 23 0.0009
884 LACRIMATION INCREASED 27 0.0009
885 JAUNDICE 24 0.0009
886 DERMATITIS ATOPIC 47 0.0009
887 ABASIA 22 0.0009
888 CHROMATURIA 20 0.0009
889 BLOOD ALKALINE PHOSPHATASE INCREASED 22 0.0009
890 BLOOD PRESSURE INCREASED 135 0.0009
891 PRESCRIBED OVERDOSE 17 0.0009
892 GASTRIC DISORDER 30 0.0009
893 EXPOSURE DURING PREGNANCY 54 0.0009
894 NEUTROPENIA 118 0.0009
895 ERECTILE DYSFUNCTION 22 0.0009
896 EOSINOPHILIA 15 0.0009
897 SURGERY 50 0.0009
898 SNEEZING 19 0.0008
899 EXTRAPYRAMIDAL DISORDER 21 0.0008
900 BLOOD URINE PRESENT 16 0.0008
901 PELVIC PAIN 15 0.0008
902 DRUG WITHDRAWAL SYNDROME 72 0.0008
903 CEREBRAL INFARCTION 20 0.0008
904 HAEMATURIA 28 0.0008
905 HEPATIC ENZYME INCREASED 55 0.0008
906 PANCYTOPENIA 45 0.0008
907 APPLICATION SITE ERYTHEMA 21 0.0008
908 BLOOD TRIGLYCERIDES INCREASED 14 0.0008
909 INJECTION SITE PRURITUS 53 0.0008
910 BONE MARROW FAILURE 16 0.0008
911 BLOOD CREATININE INCREASED 51 0.0008
912 LACTIC ACIDOSIS 25 0.0008
913 ASPARTATE AMINOTRANSFERASE INCREASED 41 0.0008
914 TOOTH LOSS 16 0.0008
915 DRUG-INDUCED LIVER INJURY 24 0.0008
916 DERMATITIS 16 0.0008
917 HEPATIC FAILURE 23 0.0008
918 THERAPEUTIC RESPONSE SHORTENED 25 0.0008
919 HEPATIC FUNCTION ABNORMAL 28 0.0007
920 SKIN CANCER 16 0.0007
921 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 40 0.0007
922 HIP FRACTURE 23 0.0007
923 FEBRILE NEUTROPENIA 47 0.0007
924 WHITE BLOOD CELL COUNT DECREASED 76 0.0007
925 DYSGEUSIA 52 0.0007
926 DRUG INEFFECTIVE 917 0.0007
927 HAEMORRHAGE 72 0.0007
928 NEUTROPHIL COUNT DECREASED 28 0.0007
929 AGEUSIA 17 0.0007
930 PSORIASIS 89 0.0007
931 BREAST CANCER FEMALE 18 0.0007
932 MULTIPLE ORGAN DYSFUNCTION SYNDROME 19 0.0007
933 SKIN BURNING SENSATION 47 0.0007
934 SKIN EXFOLIATION 55 0.0007
935 SEPTIC SHOCK 28 0.0006
936 CEREBRAL HAEMORRHAGE 23 0.0006
937 TARDIVE DYSKINESIA 18 0.0006
938 GLYCOSYLATED HAEMOGLOBIN INCREASED 16 0.0006
939 VISUAL ACUITY REDUCED 21 0.0006
940 PRODUCT COMPLAINT 16 0.0006
941 THERAPY INTERRUPTED 44 0.0006
942 SKIN IRRITATION 28 0.0006
943 DISEASE RECURRENCE 29 0.0006
944 RENAL INJURY 18 0.0006
945 PRODUCT SUBSTITUTION ISSUE 34 0.0006
946 GYNAECOMASTIA 18 0.0006
947 PROCEDURAL PAIN 16 0.0006
948 ILL-DEFINED DISORDER 35 0.0006
949 THERAPEUTIC RESPONSE UNEXPECTED 25 0.0006
950 PLATELET COUNT DECREASED 59 0.0006
951 ADVERSE EVENT 51 0.0006
952 WRONG TECHNIQUE IN DRUG USAGE PROCESS 20 0.0005
953 INJECTION SITE ERYTHEMA 68 0.0005
954 MALIGNANT NEOPLASM PROGRESSION 56 0.0005
955 ANAPHYLACTIC SHOCK 14 0.0005
956 ANHEDONIA 14 0.0005
957 EMOTIONAL DISTRESS 64 0.0005
958 INJECTION SITE BRUISING 42 0.0005
959 INJECTION SITE SWELLING 40 0.0005
960 BLOOD GLUCOSE DECREASED 25 0.0005
961 EXTRA DOSE ADMINISTERED 20 0.0005
962 INJECTION SITE RASH 15 0.0005
963 NEOPLASM PROGRESSION 17 0.0005
964 INJECTION SITE MASS 18 0.0005
965 INCORRECT DOSE ADMINISTERED 109 0.0005
966 ABORTION SPONTANEOUS 19 0.0005
967 DEVICE BREAKAGE 19 0.0005
968 DRUG ADMINISTRATION ERROR 14 0.0005
969 HOSPITALISATION 69 0.0004
970 PRODUCT ADHESION ISSUE 16 0.0004
971 INJECTION SITE PAIN 134 0.0004
972 ACNE 33 0.0004
973 UNEVALUABLE EVENT 32 0.0004
974 DISEASE PROGRESSION 50 0.0004
975 COLITIS ULCERATIVE 18 0.0004
976 INJECTION SITE REACTION 26 0.0004
977 BREAST CANCER 35 0.0004
978 ACCIDENTAL EXPOSURE TO PRODUCT 38 0.0004
979 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 17 0.0004
980 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 73 0.0004
981 VAGINAL HAEMORRHAGE 15 0.0003
982 PRODUCT QUALITY ISSUE 46 0.0003
983 DRUG DEPENDENCE 54 0.0003
984 DRUG EFFECT DECREASED 18 0.0003
985 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 21 0.0003
986 UNDERDOSE 21 0.0003
987 DEATH 240 0.0003
988 DRUG DOSE OMISSION 42 0.0003
989 PRODUCT DOSE OMISSION 16 0.0002
990 INJECTION SITE HAEMORRHAGE 19 0.0002
991 NO ADVERSE EVENT 33 0.0002